AstraZeneca Newsroom

AstraZeneca (AZN) Receives a Sell From UBS

TipRanksAug 13 09:09 ET

AstraZeneca Price Target Raised to $95.00/Share From $90.00 by TD Cowen

Dow JonesAug 12 11:09 ET

AstraZeneca Analyst Ratings

BenzingaAug 12 10:59 ET

TD Cowen Sticks to Their Buy Rating for AstraZeneca (AZN)

TipRanksAug 12 07:35 ET

AstraZeneca: A Buy Rating Justified by Strong Growth Potential and Robust Pipeline

TipRanksJul 30 05:27 ET

Deutsche Bank Reaffirms Their Hold Rating on AstraZeneca (AZN)

TipRanksJul 29 06:31 ET

Kepler Capital Remains a Hold on AstraZeneca (AZN)

TipRanksJul 26 21:51 ET

AstraZeneca (AZN) Receives a Hold From DZ BANK AG

TipRanksJul 26 09:37 ET

BMO Capital Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $89

Moomoo NewsJul 26 07:34 ET

Leerink Partners Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $136

Moomoo NewsJul 26 02:33 ET

AstraZeneca's Strong Q2 Performance and Positive Outlook Justify Buy Rating

TipRanksJul 26 02:02 ET

Jefferies Remains a Hold on AstraZeneca (AZN)

TipRanksJul 25 10:07 ET

TD Cowen Maintains AstraZeneca(AZN.US) With Buy Rating

Moomoo NewsJul 25 08:31 ET

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), AstraZeneca (AZN) and Icon (ICLR)

TipRanksJul 25 08:28 ET

AstraZeneca: Strong Q2 Performance and Promising Pipeline Justify Buy Rating

TipRanksJul 25 06:15 ET

UBS Sticks to Its Sell Rating for AstraZeneca (AZN)

TipRanksJul 24 04:20 ET

AstraZeneca: Strong Growth and Resilience Justify Buy Rating

TipRanksJul 23 06:11 ET

Deutsche Numis Reaffirms Their Hold Rating on AstraZeneca (AZN)

TipRanksJul 10 07:09 ET

Barclays Sticks to Its Buy Rating for AstraZeneca (AZN)

TipRanksJul 10 01:42 ET

AstraZeneca: Strong Sales Growth and Upward Guidance Potential Justify Buy Rating

TipRanksJul 8 06:28 ET